JP2007505081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505081A5 JP2007505081A5 JP2006525794A JP2006525794A JP2007505081A5 JP 2007505081 A5 JP2007505081 A5 JP 2007505081A5 JP 2006525794 A JP2006525794 A JP 2006525794A JP 2006525794 A JP2006525794 A JP 2006525794A JP 2007505081 A5 JP2007505081 A5 JP 2007505081A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- substituted
- cor
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims 21
- 229910052799 carbon Inorganic materials 0.000 claims 10
- 229910052760 oxygen Inorganic materials 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 125000002877 alkyl aryl group Chemical group 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 239000003153 chemical reaction reagent Substances 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 125000003107 substituted aryl group Chemical group 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 2
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- DRNXZLHDIMEWHO-UHFFFAOYSA-N 2-[2-(1,3-dioxoisoindol-2-yl)ethyl]-3-hydroxy-5-(4-pyrimidin-5-ylphenyl)pentanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCC(C(O)=O)C(O)CCC(C=C1)=CC=C1C1=CN=CN=C1 DRNXZLHDIMEWHO-UHFFFAOYSA-N 0.000 claims 1
- TYNXKLBAMDKDHF-UHFFFAOYSA-N 3-hydroxy-2-[2-(3-methyl-2,4-dioxopyrimidin-1-yl)ethyl]-5-(4-phenylphenyl)pentanoic acid Chemical compound O=C1N(C)C(=O)C=CN1CCC(C(O)=O)C(O)CCC1=CC=C(C=2C=CC=CC=2)C=C1 TYNXKLBAMDKDHF-UHFFFAOYSA-N 0.000 claims 1
- WRTBLWFQLQBUBR-UHFFFAOYSA-N 3-hydroxy-2-[2-(3-methyl-2,4-dioxopyrimidin-1-yl)ethyl]-5-[4-[4-(trifluoromethoxy)phenyl]phenyl]pentanoic acid Chemical compound O=C1N(C)C(=O)C=CN1CCC(C(O)=O)C(O)CCC1=CC=C(C=2C=CC(OC(F)(F)F)=CC=2)C=C1 WRTBLWFQLQBUBR-UHFFFAOYSA-N 0.000 claims 1
- BHLJQPGIHDTZBX-UHFFFAOYSA-N 3-hydroxy-2-[2-(3-methyl-2,6-dioxopyrimidin-1-yl)ethyl]-5-(4-phenylphenyl)pentanoic acid Chemical compound O=C1N(C)C=CC(=O)N1CCC(C(O)=O)C(O)CCC1=CC=C(C=2C=CC=CC=2)C=C1 BHLJQPGIHDTZBX-UHFFFAOYSA-N 0.000 claims 1
- NAAQNJLBTAIZDO-UHFFFAOYSA-N 5-[4-(1-benzofuran-2-yl)phenyl]-2-[2-(1,3-dioxoisoindol-2-yl)ethyl]-3-hydroxypentanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCC(C(O)=O)C(O)CCC1=CC=C(C=2OC3=CC=CC=C3C=2)C=C1 NAAQNJLBTAIZDO-UHFFFAOYSA-N 0.000 claims 1
- KXJLRFIYARWGFH-UHFFFAOYSA-N 5-[4-(4-acetylphenyl)phenyl]-2-[2-(1,3-dioxoisoindol-2-yl)ethyl]-3-hydroxypentanoic acid Chemical compound C1=CC(C(=O)C)=CC=C1C(C=C1)=CC=C1CCC(O)C(C(O)=O)CCN1C(=O)C2=CC=CC=C2C1=O KXJLRFIYARWGFH-UHFFFAOYSA-N 0.000 claims 1
- MSYHSDYSURKJEX-UHFFFAOYSA-N 5-[4-(4-acetylphenyl)phenyl]-3-hydroxy-2-[2-(3-methyl-2,4-dioxopyrimidin-1-yl)ethyl]pentanoic acid Chemical compound C1=CC(C(=O)C)=CC=C1C(C=C1)=CC=C1CCC(O)C(C(O)=O)CCN1C(=O)N(C)C(=O)C=C1 MSYHSDYSURKJEX-UHFFFAOYSA-N 0.000 claims 1
- UIZCUKPUFVLHGU-UHFFFAOYSA-N 5-[4-(4-cyanophenyl)phenyl]-2-[2-(1,3-dioxoisoindol-2-yl)ethyl]-3-hydroxypentanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCC(C(O)=O)C(O)CCC(C=C1)=CC=C1C1=CC=C(C#N)C=C1 UIZCUKPUFVLHGU-UHFFFAOYSA-N 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- KDSNLLCOUMXHFV-UHFFFAOYSA-N CC(CCN1C(=O)C2=CC=CC=C2C1=O)C(CCC3=CC=C(C=C3)C4=CC=C(C=C4)SC)O Chemical compound CC(CCN1C(=O)C2=CC=CC=C2C1=O)C(CCC3=CC=C(C=C3)C4=CC=C(C=C4)SC)O KDSNLLCOUMXHFV-UHFFFAOYSA-N 0.000 claims 1
- OVHDDQBXGFOIAB-UHFFFAOYSA-N CC(CCN1C=CC(=O)N(C1=O)C)C(CCC2=CC=C(C=C2)C3=CN=CN=C3)O Chemical compound CC(CCN1C=CC(=O)N(C1=O)C)C(CCC2=CC=C(C=C2)C3=CN=CN=C3)O OVHDDQBXGFOIAB-UHFFFAOYSA-N 0.000 claims 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 150000003462 sulfoxides Chemical class 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000006168 tricyclic group Chemical group 0.000 claims 1
- 0 Cc1ccc(CCC(C(CCNCCCCCC*)C(O)=*)O)cc1 Chemical compound Cc1ccc(CCC(C(CCNCCCCCC*)C(O)=*)O)cc1 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0321538.1A GB0321538D0 (en) | 2003-09-13 | 2003-09-13 | Therapeutically useful compounds |
| PCT/EP2004/010319 WO2005026120A1 (en) | 2003-09-13 | 2004-09-10 | Matrix metalloproteinase inhibitors |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011132261A Division JP2011231118A (ja) | 2003-09-13 | 2011-06-14 | マトリックスメタロプロテイナーゼの阻害剤 |
| JP2012012663A Division JP2012107031A (ja) | 2003-09-13 | 2012-01-25 | マトリックスメタロプロテイナーゼの阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505081A JP2007505081A (ja) | 2007-03-08 |
| JP2007505081A5 true JP2007505081A5 (https=) | 2007-10-25 |
Family
ID=29227079
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525794A Pending JP2007505081A (ja) | 2003-09-13 | 2004-09-10 | マトリックスメタロプロテイナーゼの阻害剤 |
| JP2011132261A Withdrawn JP2011231118A (ja) | 2003-09-13 | 2011-06-14 | マトリックスメタロプロテイナーゼの阻害剤 |
| JP2012012663A Pending JP2012107031A (ja) | 2003-09-13 | 2012-01-25 | マトリックスメタロプロテイナーゼの阻害剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011132261A Withdrawn JP2011231118A (ja) | 2003-09-13 | 2011-06-14 | マトリックスメタロプロテイナーゼの阻害剤 |
| JP2012012663A Pending JP2012107031A (ja) | 2003-09-13 | 2012-01-25 | マトリックスメタロプロテイナーゼの阻害剤 |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US7601729B2 (https=) |
| EP (3) | EP2042488B1 (https=) |
| JP (3) | JP2007505081A (https=) |
| KR (3) | KR20130079628A (https=) |
| CN (1) | CN1849306B (https=) |
| AT (2) | ATE502922T1 (https=) |
| AU (1) | AU2004272280C1 (https=) |
| BR (1) | BRPI0413791A (https=) |
| CA (1) | CA2538315C (https=) |
| CY (1) | CY1109400T1 (https=) |
| DE (2) | DE602004031991D1 (https=) |
| DK (1) | DK1663970T3 (https=) |
| ES (2) | ES2362954T3 (https=) |
| GB (1) | GB0321538D0 (https=) |
| HR (1) | HRP20080668T3 (https=) |
| IL (1) | IL173305A (https=) |
| IS (2) | IS2622B (https=) |
| MA (1) | MA28039A1 (https=) |
| MX (1) | MXPA06002458A (https=) |
| NO (1) | NO20060540L (https=) |
| NZ (2) | NZ545211A (https=) |
| PL (1) | PL1663970T3 (https=) |
| PT (1) | PT1663970E (https=) |
| RU (2) | RU2370488C2 (https=) |
| SG (1) | SG145685A1 (https=) |
| SI (1) | SI1663970T1 (https=) |
| WO (1) | WO2005026120A1 (https=) |
| ZA (1) | ZA200602070B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0321538D0 (en) * | 2003-09-13 | 2003-10-15 | Glaxo Group Ltd | Therapeutically useful compounds |
| CA2598518C (en) * | 2005-02-22 | 2015-04-21 | Ranbaxy Laboratories Limited | 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| ES2397284T3 (es) | 2006-08-22 | 2013-03-06 | Ranbaxy Laboratories Limited | Proceso para preparar inhibidores de la metaloproteinasa de la matriz y auxiliares quirales para los mismos |
| AU2013200728B2 (en) * | 2006-08-22 | 2014-12-18 | Sun Pharmaceutical Industries Limited | Matrix metalloproteinase inhibitors |
| EP2520561B1 (en) | 2007-06-08 | 2016-02-10 | MannKind Corporation | IRE-1A Inhibitors |
| FR2949463B1 (fr) * | 2009-08-26 | 2011-09-16 | Commissariat Energie Atomique | Inhibiteurs de mmp |
| SG187654A1 (en) | 2010-07-30 | 2013-03-28 | Ranbaxy Lab Ltd | Matrix metalloproteinase inhibitors |
| CA2812319A1 (en) | 2010-09-24 | 2012-03-29 | Ranbaxy Laboratories Limited | Matrix metalloproteinase inhibitors |
| EP2926808A1 (en) | 2012-11-28 | 2015-10-07 | Administración General De La Communidad Autónoma De Euskadi | Use of metalloprotease inhibitors for the treatment of polycystic liver diseases |
| BR112018016475A2 (en) | 2016-02-12 | 2018-12-26 | Cytokinetics, Incorporated | tetrahydroisoquinoline derivatives |
| JP7143334B2 (ja) * | 2017-06-13 | 2022-09-28 | エシコン エルエルシー | 治癒を制御させる手術用ステープラ |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| WO1995029901A1 (en) * | 1994-04-28 | 1995-11-09 | Uniroyal Chemical Company, Inc. | Fungicidal azole derivatives |
| CZ172498A3 (cs) * | 1995-12-06 | 1998-12-16 | Astra Pharmaceuticals Ltd. | Sloučenina |
| WO1997040027A1 (en) * | 1996-04-19 | 1997-10-30 | Akzo Nobel N.V. | Substituted benzylamines and their use for the treatment of depression |
| TNSN97085A1 (fr) | 1996-05-15 | 2005-03-15 | Bayer Corp | Substitution oxybuterique des acides comme inhibiteurs de la matrice metalloprotease |
| US6870058B2 (en) | 1996-12-03 | 2005-03-22 | The Trustees Of The University Of Pennsylvania | Compounds which mimic the chemical and biological properties of discodermolide |
| US6242616B1 (en) | 1996-12-03 | 2001-06-05 | The Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| US5789605A (en) | 1996-12-03 | 1998-08-04 | Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof |
| US20050065353A1 (en) | 1996-12-03 | 2005-03-24 | Smith Amos B. | Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| US6096904A (en) | 1996-12-03 | 2000-08-01 | The Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| US5804581A (en) * | 1997-05-15 | 1998-09-08 | Bayer Corporation | Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| US6608052B2 (en) * | 2000-02-16 | 2003-08-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as anti-inflammatory agents |
| MXPA03009361A (es) * | 2001-04-13 | 2004-01-29 | Boehringer Ingelheim Pharma | Compuestos de urea utilies como agentes anti-inflamatorios. |
| WO2004012663A2 (en) * | 2002-08-01 | 2004-02-12 | Bristol-Myers Squibb Company | Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| ATE455096T1 (de) * | 2002-11-19 | 2010-01-15 | Galderma Res & Dev | Biaromatische verbindungen die ppar-gamma rezeptoren aktivieren und deren anwendungen in kosmetischen oder pharmazeutischen zusammensetzungen |
| GB0312654D0 (en) * | 2003-06-03 | 2003-07-09 | Glaxo Group Ltd | Therapeutically useful compounds |
| GB0314488D0 (en) * | 2003-06-20 | 2003-07-23 | Glaxo Group Ltd | Therapeutically useful compounds |
| GB0319069D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Therapeutically useful compounds |
| GB0321538D0 (en) * | 2003-09-13 | 2003-10-15 | Glaxo Group Ltd | Therapeutically useful compounds |
| CA2598518C (en) | 2005-02-22 | 2015-04-21 | Ranbaxy Laboratories Limited | 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| ES2397284T3 (es) | 2006-08-22 | 2013-03-06 | Ranbaxy Laboratories Limited | Proceso para preparar inhibidores de la metaloproteinasa de la matriz y auxiliares quirales para los mismos |
-
2003
- 2003-09-13 GB GBGB0321538.1A patent/GB0321538D0/en not_active Ceased
-
2004
- 2004-09-10 RU RU2006106850/04A patent/RU2370488C2/ru not_active IP Right Cessation
- 2004-09-10 KR KR1020137014317A patent/KR20130079628A/ko not_active Ceased
- 2004-09-10 CN CN200480026229.7A patent/CN1849306B/zh not_active Expired - Fee Related
- 2004-09-10 KR KR1020127000264A patent/KR20120007566A/ko not_active Ceased
- 2004-09-10 NZ NZ545211A patent/NZ545211A/en not_active IP Right Cessation
- 2004-09-10 WO PCT/EP2004/010319 patent/WO2005026120A1/en not_active Ceased
- 2004-09-10 JP JP2006525794A patent/JP2007505081A/ja active Pending
- 2004-09-10 EP EP08163972A patent/EP2042488B1/en not_active Expired - Lifetime
- 2004-09-10 EP EP10176905A patent/EP2295408A1/en not_active Withdrawn
- 2004-09-10 PT PT04765231T patent/PT1663970E/pt unknown
- 2004-09-10 AU AU2004272280A patent/AU2004272280C1/en not_active Ceased
- 2004-09-10 EP EP04765231A patent/EP1663970B1/en not_active Expired - Lifetime
- 2004-09-10 HR HR20080668T patent/HRP20080668T3/xx unknown
- 2004-09-10 KR KR1020067005114A patent/KR20060120648A/ko not_active Ceased
- 2004-09-10 BR BRPI0413791-4A patent/BRPI0413791A/pt not_active IP Right Cessation
- 2004-09-10 ES ES08163972T patent/ES2362954T3/es not_active Expired - Lifetime
- 2004-09-10 ES ES04765231T patent/ES2314436T3/es not_active Expired - Lifetime
- 2004-09-10 DK DK04765231T patent/DK1663970T3/da active
- 2004-09-10 SG SG200805432-2A patent/SG145685A1/en unknown
- 2004-09-10 US US10/571,443 patent/US7601729B2/en not_active Expired - Fee Related
- 2004-09-10 DE DE602004031991T patent/DE602004031991D1/de not_active Expired - Lifetime
- 2004-09-10 CA CA2538315A patent/CA2538315C/en not_active Expired - Fee Related
- 2004-09-10 SI SI200431008T patent/SI1663970T1/sl unknown
- 2004-09-10 AT AT08163972T patent/ATE502922T1/de not_active IP Right Cessation
- 2004-09-10 PL PL04765231T patent/PL1663970T3/pl unknown
- 2004-09-10 AT AT04765231T patent/ATE413384T1/de active
- 2004-09-10 NZ NZ573479A patent/NZ573479A/en not_active IP Right Cessation
- 2004-09-10 DE DE602004017622T patent/DE602004017622D1/de not_active Expired - Lifetime
- 2004-09-10 MX MXPA06002458A patent/MXPA06002458A/es active IP Right Grant
-
2006
- 2006-01-23 IL IL173305A patent/IL173305A/en not_active IP Right Cessation
- 2006-01-26 IS IS8268A patent/IS2622B/is unknown
- 2006-02-02 NO NO20060540A patent/NO20060540L/no not_active Application Discontinuation
- 2006-03-10 ZA ZA200602070A patent/ZA200602070B/en unknown
- 2006-03-14 MA MA28873A patent/MA28039A1/fr unknown
-
2008
- 2008-11-07 US US12/266,767 patent/US8263602B2/en not_active Expired - Fee Related
- 2008-11-26 RU RU2008146479/04A patent/RU2008146479A/ru not_active Application Discontinuation
-
2009
- 2009-01-27 CY CY20091100090T patent/CY1109400T1/el unknown
- 2009-08-19 IS IS8843A patent/IS8843A/is unknown
- 2009-09-01 US US12/551,892 patent/US8343986B2/en not_active Expired - Fee Related
-
2011
- 2011-06-14 JP JP2011132261A patent/JP2011231118A/ja not_active Withdrawn
-
2012
- 2012-01-25 JP JP2012012663A patent/JP2012107031A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008146479A (ru) | Ингибиторы матриксных металлопротеиназ | |
| RU2542099C2 (ru) | N-фенил-диоксо-гидропиримидины, используемые в качестве ингибитора вируса гепатита с (hcv) | |
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| ES2456673T3 (es) | Compuestos basados en imidazol, composiciones que los comprenden y métodos para usarlos | |
| JP2007505081A5 (https=) | ||
| CA2440473A1 (en) | Metalloproteinase inhibitors | |
| RU2005128190A (ru) | Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации | |
| JP2002529532A5 (https=) | ||
| JP2010031025A5 (https=) | ||
| ES2925186T3 (es) | Compuestos y su uso para reducir los niveles de ácido úrico | |
| JP2018535967A5 (https=) | ||
| CA2315715A1 (en) | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas | |
| PT2639226T (pt) | Pirimidinas anti-infeciosas e suas utilizações | |
| JP2007511527A5 (https=) | ||
| US9084828B2 (en) | Oligomer-protein tyrosine kinase inhibitor conjugates | |
| JP2006501201A5 (https=) | ||
| CA2214338A1 (en) | Use of .alpha.1l agonists for treating urinary incontinence | |
| JP2005522458A5 (https=) | ||
| JP2005529155A5 (https=) | ||
| RU2003127736A (ru) | Ингибитора металлопротеиназ | |
| EP3733665B1 (en) | 2-oxo-1,3,4-thiadiazinan-3-yl moiety containing compounds with ep4 receptor agonist activity | |
| JP2006507355A5 (https=) | ||
| RU2009133846A (ru) | Новые производные гидантоина в качестве ингибиторов металлопротеиназ | |
| BG61341B1 (en) | 4- alkylimidazole derivatives | |
| HU214872B (hu) | Eljárás farmakológiailag aktív új katecholszármazékok és ezeket tartalmazó gyógyászati készítmények előállítására |